| Patent application number | Description | Published |
|---|
| 20090118319 | Fused and Spirocycle Compounds and the Use Thereof - The invention relates to fused and spirocycle compounds of Formula (I), or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein R | 05-07-2009 |
| 20090239910 | Benzenesulfonamide Compounds and Their Use - The invention relates to azetidinyl, pyrrolidinyl, piperidinyl, and hexahydroazepinyl compounds of Formula I and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein R | 09-24-2009 |
| 20090291947 | PROLINE ANALOGS AS LIGANDS FOR CANNABINOID RECEPTORS - The present invention relates to Proline Analog Compounds that are ligands for cannabinoid receptors, compositions comprising a Proline Analog Compound and a pharmaceutically-acceptable carrier, methods of making such Proline Analog Compounds, and methods for treating or preventing a Condition comprising administering an effective amount of a Proline Analog Compound to an animal in need thereof. | 11-26-2009 |
| 20090306136 | Benzenesulfonamide Compounds and the Use Thereof - The invention relates to azetidinyl, pyrrolidinyl, piperidinyl, and hexahydroazepinyl compounds of Formula (I): and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein R | 12-10-2009 |
| 20100022595 | Benzenesulfonamide Compounds and Their Use as Blockers of Calcium Channels - The invention relates to piperidinyl and hexahydroazepinyl compounds of Formula (I): and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein R | 01-28-2010 |
| 20100063030 | Benzenesulfonyl Compounds and the Use Thereof - The invention relates to pyrrolidinyl, piperidinyl, and hexahydroazepinyl compounds of Formula I: and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein R | 03-11-2010 |
| 20110098281 | Benzenesulfonyl Compounds and the Use Thereof - The invention relates to pyrrolidinyl, piperidinyl, and hexahydroazepinyl compounds of Formula I: and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein R | 04-28-2011 |
